NCT02654743View on ClinicalTrials.gov

Open Label of Clinical Trial of Sulforaphane in Children With Autism

PHASE3CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

September 30, 2016

Conditions
Autism
Interventions
DIETARY_SUPPLEMENT

Sulforaphane

Children with ASD will receive Sulforaphane in this study

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT02654743 - Open Label of Clinical Trial of Sulforaphane in Children With Autism | Biotech Hunter | Biotech Hunter